Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2024-06-13 00:00:00 ET · period of report 2024-06-11 · accession 0000950170-24-073290 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-13 | 2024-06-11 | MDGL | CRAVES FRED B | Dir | G - Gift | $0.00 | -39.0K | 374.4K | -9% | $0 | |
| I | 2024-06-13 | 2024-06-11 | MDGL | CRAVES FRED B | Dir | G - Gift | $0.00 | -45.9K | 11.2K | -80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-11 | G | D | 39,000 | $0.00 | 374,362 | D See Footnote | — | — | (F1) Represents shares held indirectly by Dr. Craves through a grantor retained annuity trust. |
| 2 | Common | Common Stock | 2024-06-11 | G | D | 45,852 | $0.00 | 11,210 | I | — | — |